258 related articles for article (PubMed ID: 38258033)
1. Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy.
An X; Zeng Y; Liu C; Liu G
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258033
[TBL] [Abstract][Full Text] [Related]
2. Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy.
Xu C; Ju D; Zhang X
Front Immunol; 2022; 13():923598. PubMed ID: 35874757
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy.
Xiao Y; Wu M; Xue C; Wang Y
Curr Drug Deliv; 2024; 21(3):403-420. PubMed ID: 37143265
[TBL] [Abstract][Full Text] [Related]
4. Cell membrane-derived vesicles for delivery of therapeutic agents.
Le QV; Lee J; Lee H; Shim G; Oh YK
Acta Pharm Sin B; 2021 Aug; 11(8):2096-2113. PubMed ID: 34522579
[TBL] [Abstract][Full Text] [Related]
5. Application of lipid nanovesicle drug delivery system in cancer immunotherapy.
Ding Y; Wang L; Li H; Miao F; Zhang Z; Hu C; Yu W; Tang Q; Shao G
J Nanobiotechnology; 2022 May; 20(1):214. PubMed ID: 35524277
[TBL] [Abstract][Full Text] [Related]
6. Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.
Harisa GI; Sherif AY; Youssof AME; Alanazi FK; Salem-Bekhit MM
AAPS PharmSciTech; 2020 Jun; 21(5):168. PubMed ID: 32514657
[TBL] [Abstract][Full Text] [Related]
7. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles.
Wang J; Zhu M; Nie G
Adv Drug Deliv Rev; 2021 Nov; 178():113974. PubMed ID: 34530015
[TBL] [Abstract][Full Text] [Related]
8. Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.
Yang P; Peng Y; Feng Y; Xu Z; Feng P; Cao J; Chen Y; Chen X; Cao X; Yang Y; Jie J
Front Immunol; 2021; 12():771551. PubMed ID: 34956197
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.
Xu J; Cao W; Wang P; Liu H
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890175
[TBL] [Abstract][Full Text] [Related]
10. Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers.
Baldassari S; Balboni A; Drava G; Donghia D; Canepa P; Ailuno G; Caviglioli G
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242687
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy.
Chen H; Sun T; Jiang C
J Control Release; 2022 Aug; 348():572-589. PubMed ID: 35714733
[TBL] [Abstract][Full Text] [Related]
12. The tremendous biomedical potential of bacterial extracellular vesicles.
Xie J; Li Q; Haesebrouck F; Van Hoecke L; Vandenbroucke RE
Trends Biotechnol; 2022 Oct; 40(10):1173-1194. PubMed ID: 35581020
[TBL] [Abstract][Full Text] [Related]
13. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
Ahmadi M; Hassanpour M; Rezaie J
Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
[TBL] [Abstract][Full Text] [Related]
14. Emerging Opportunities and Challenges in Cancer Immunotherapy.
Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
[TBL] [Abstract][Full Text] [Related]
15. Engineered cellular immunotherapies in cancer and beyond.
Finck AV; Blanchard T; Roselle CP; Golinelli G; June CH
Nat Med; 2022 Apr; 28(4):678-689. PubMed ID: 35440724
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles-based drug delivery systems for cancer immunotherapy.
Yong T; Li X; Wei Z; Gan L; Yang X
J Control Release; 2020 Dec; 328():562-574. PubMed ID: 32946875
[TBL] [Abstract][Full Text] [Related]
17. Cell-Membrane-Based Biomimetic Systems with Bioorthogonal Functionalities.
Huang LL; Nie W; Zhang J; Xie HY
Acc Chem Res; 2020 Jan; 53(1):276-287. PubMed ID: 31913016
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Injectable hydrogels for personalized cancer immunotherapies.
Mohaghegh N; Ahari A; Zehtabi F; Buttles C; Davani S; Hoang H; Tseng K; Zamanian B; Khosravi S; Daniali A; Kouchehbaghi NH; Thomas I; Serati Nouri H; Khorsandi D; Abbasgholizadeh R; Akbari M; Patil R; Kang H; Jucaud V; Khademhosseini A; Hassani Najafabadi A
Acta Biomater; 2023 Dec; 172():67-91. PubMed ID: 37806376
[TBL] [Abstract][Full Text] [Related]
20. Bacterial extracellular vesicle applications in cancer immunotherapy.
Suri K; D'Souza A; Huang D; Bhavsar A; Amiji M
Bioact Mater; 2023 Apr; 22():551-566. PubMed ID: 36382022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
